Alteminostat

DB19620InvestigationalSmall molecule

Alteminostat is a small molecule drug. The usage of the INN stem '-inostat' in the name indicates that Alteminostat is a histone deacetylase inhibitor. Alteminostat is under investigation in clinical... Alteminostat is under investigation in clinical trial NCT03051841 (CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma).

Mechanism: Pharmacologically active on Histone deacetylase
Curator reviewed
Formula / weight: C₂₇H₃₆N₆O₃ · 492.624 g/mol (avg)
Code names: CKD-581

Resolves to

Compound

UNII1FM6TS1M0GCAS1246374-97-9ChEMBLCHEMBL5314954ChEBI759645PubChem58074180

Structure

InChIKeyYEQGPOVCXMZUBT-UHFFFAOYSA-NSMILESCN1N=CC2=CC=C(C=C12)C1=CC=C(C=C1)N(CCCCCCC(=O)NO)C(=O)N1CCN(C)CC1

What you can answer from here — as of September 23, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which companies are running trials of Alteminostat, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account